Theophylline toxicity: Difference between revisions

Line 38: Line 38:


==Management==
==Management==
*GI decontamination ([[Multidose Activated Charcoal]], [[Whole Bowel Irrigation]])
#Supportive care
**Considered in life-threatening overdose
#*Cardiac monitoring
***contraindications: unsecured airway, [[nausea]], [[vomiting]], ileus, [[Bowel Obstruction]], or need for emergent endoscopy
#*Ondansetron (Zofran) for antiemetic
*[[Seizures]]
#*EEG for sedated and paralyzed patients
**[[Lorazepam]] (Ativan) 1st line
#Cardiovascular
**Phenobarbital if [[lorazepam]] ineffective
#*[[IV Fluids]] for [[hypotension]]
**Phenytoin (Dilantin) contraindicated as increases seizure in animal studies
#*Beta blockers for [[tachyarrhymias]]
*Cardiovascular
#**Controversial, involve a toxicologist
**[[IV Fluids]] for [[hypotension]]
#GI decontamination ([[Multidose Activated Charcoal]], [[Whole Bowel Irrigation]])
**Beta blockers for [[tachyarrhymias]]
#*Considered in life-threatening overdose
***Controversial, involve a toxicologist
#**contraindications: unsecured airway, [[nausea]], [[vomiting]], ileus, [[Bowel Obstruction]], or need for emergent endoscopy
*Dialysis
#[[Seizures]]
**Indicated in [[seizures]], severe [[arrhythmias]]
#*[[Lorazepam]] (Ativan) 1st line
**Theophylline level >90mcg/ml in acute ingestion
#*Phenobarbital if [[lorazepam]] ineffective
**Theophylline level >40mcg/ml in chronic ingestion
#*Phenytoin (Dilantin) contraindicated as increases seizure in animal studies
*Supportive care
#Dialysis
**Cardiac monitoring
#*Indicated in [[seizures]], severe [[arrhythmias]]
**Ondansetron (Zofran) for antiemetic
#*Theophylline level >90mcg/ml in acute ingestion
**EEG for sedated and paralyzed patients
#*Theophylline level >40mcg/ml in chronic ingestion


==Disposition==
==Disposition==

Revision as of 22:26, 20 September 2016

See theophylline for general drug information

Background

  • Still used in patients with debilitating brochospastic disease
  • Studied for treatment of Acute Mountain Sickness and Contrast-Induced Nephropathy
  • PO in elixir, extended release, or controlled release forms but absorption erratic
  • IV as aminophylline
  • Adenosine antagonism, Increase catecholamines, and Phosphodiesterase inhibition

Clinical Features

Differential Diagnosis

Evaluation

  • ECG
  • Chem
  • CK
  • Theophylline level

Management

  1. Supportive care
    • Cardiac monitoring
    • Ondansetron (Zofran) for antiemetic
    • EEG for sedated and paralyzed patients
  2. Cardiovascular
  3. GI decontamination (Multidose Activated Charcoal, Whole Bowel Irrigation)
  4. Seizures
    • Lorazepam (Ativan) 1st line
    • Phenobarbital if lorazepam ineffective
    • Phenytoin (Dilantin) contraindicated as increases seizure in animal studies
  5. Dialysis
    • Indicated in seizures, severe arrhythmias
    • Theophylline level >90mcg/ml in acute ingestion
    • Theophylline level >40mcg/ml in chronic ingestion

Disposition

Immediate release

  • Home after 6 hours if:
    • nontoxic
    • asymptomatic
    • and, normal vital sign

Sustained release

  • Home after 12 hours if:
    • nontoxic
    • asymptomatic
    • and, normal vital sign

See Also

External Links

References